Unknown

Dataset Information

0

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.


ABSTRACT:

SUBMITTER: Beigel JH 

PROVIDER: S-EPMC6941345 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Infection with influenza virus causes substantial morbidity and mortality globally, although antiviral treatments are available. Previous studies have suggested that anti-influenza immune plasma could be beneficial as treatment, but they were not designed as randomised, blinded, placebo-controlled trials. Therefore, we aimed to prospectively evaluate the clinical efficacy of high-titre immune plasma compared with standard low-titre plasma to improve outcomes in patients with s  ...[more]

Similar Datasets

| S-EPMC5828518 | biostudies-literature
| S-EPMC5521248 | biostudies-literature
| S-EPMC10009502 | biostudies-literature
| S-EPMC9205279 | biostudies-literature
| S-EPMC4574625 | biostudies-literature
| S-EPMC3668094 | biostudies-literature
| S-EPMC7164783 | biostudies-literature
| S-EPMC7613263 | biostudies-literature
| S-EPMC8078879 | biostudies-literature